Goto Shinya

Փ��

Development of the Integrated Computer Simulation Model of the Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin �� IIb �� 3 (Platelet Membrane Glycoprotein: GPIIb-IIIa).

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke.

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry.

Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active Cancer in a Nation With an Overall Low Risk of Thrombosis.

Dual Antiplatelet Therapy or Dual Pathway Inhibition.

Clinical outcomes in older patients with atrial fibrillation: insights from the GARFIELD-AF registry.

Asian Perspective on the Recently Published Practice Guideline for Acute Coronary Syndrome by ESC.

MRP1-Dependent Extracellular Release of Glutathione Induces Cardiomyocyte Ferroptosis After Ischemia-Reperfusion.

Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?

Acute pulmonary hypertension due to microthrombus formation following COVID-19 vaccination: a case report.

Long-term outcome of chronic thromboembolic pulmonary hypertension in the era where direct oral anticoagulants become available.

Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination.

Empagliflozin in Patients with Chronic Kidney Disease.

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day.

��ͬ�о�?�������Y��Ȥ��о��n�}

Antithrombogenic/flexible carbon-based nano-coating for superelastic Nitinol alloy stent in peripheral arterial disease.

Elucidation of smoking-sensitive genes in chronic obstructive pulmonary disease with genomic analysis

Individualization of anticoagulation therapy of warfarin based on pharmacogenetic information

Clarification of the Mechanism of Arterial Thrombus Formation by Dynamic Functional Imaging of Platelets

Redox-regulation by active oxygen species / nitric oxide in cardiovascular system

Mechanism of Procoagulant Activity Appearing on the Surface of Activated Platelet and New Development of Anttithrombotic Therapy by Its Inhibition.

An attempt to clarify the cause of "Pokkuri disease", a special type of sudden cardiac death, via Forensic Medicine.

The mechanism of platelet thrombus formation at site of endothelial damage under blood flow conditions